Videos
Importance of Diversity & Equal Opportunities in a Healthy R&D Environment: Diversity and inclusion in
07 June 2022Statements
IFPMA, GSCF, and DITTA Statement on Health Emergencies for WHA75 agenda item 16.2
24 May 2022News Releases
Improving access to and use of essential life-saving cancer medicines in LLMICs
23 May 2022News Releases
Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate
22 May 2022Publications
Applying Lessons Learned from COVID-19 to Create a Healthier, Safer, More Equitable World
22 May 2022Position Papers
Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles
20 May 2022Publications